79 related articles for article (PubMed ID: 17238877)
1. Stroke caused by small vessel occlusion in a patient taking etoricoxib and thalidomide.
Wong EH; Leung TW; Wong KS
J Neuroimaging; 2007 Jan; 17(1):87-8. PubMed ID: 17238877
[TBL] [Abstract][Full Text] [Related]
2. Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Schwartz JI; Agrawal NG; Wong PH; Miller J; Bachmann K; Marbury T; Hoelscher D; Cavanaugh PF; Gottesdiener K
J Clin Pharmacol; 2009 Oct; 49(10):1202-9. PubMed ID: 19783714
[TBL] [Abstract][Full Text] [Related]
3. Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis.
Croom KF; Siddiqui MA
Drugs; 2009 Jul; 69(11):1513-32. PubMed ID: 19634927
[TBL] [Abstract][Full Text] [Related]
4. Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement.
Duarte AF; Correia O; Azevedo R; do Carmo Palmares M; Delgado L
Eur J Dermatol; 2010; 20(2):236-8. PubMed ID: 20110201
[No Abstract] [Full Text] [Related]
5. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
El Miedany Y; Youssef S; Ahmed I; El Gaafary M
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
[TBL] [Abstract][Full Text] [Related]
6. A case report on toxic epidermal necrolysis with etoricoxib.
Kameshwari JS; Devde R
Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388
[TBL] [Abstract][Full Text] [Related]
7. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Laine L; Curtis SP; Cryer B; Kaur A; Cannon CP;
Lancet; 2007 Feb; 369(9560):465-73. PubMed ID: 17292766
[TBL] [Abstract][Full Text] [Related]
8. The Vioxx fallout.
Palmer K
Minn Med; 2005 Mar; 88(3):26-30. PubMed ID: 15852592
[No Abstract] [Full Text] [Related]
9. Reversible cerebral vasoconstriction syndrome possibly induced by etoricoxib.
Dallocchio C; Arbasino C; Borutti G; Gola G; Egitto MG
Clin Neuropharmacol; 2014; 37(5):154-7. PubMed ID: 25229174
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Cannon CP; Curtis SP; FitzGerald GA; Krum H; Kaur A; Bolognese JA; Reicin AS; Bombardier C; Weinblatt ME; van der Heijde D; Erdmann E; Laine L;
Lancet; 2006 Nov; 368(9549):1771-81. PubMed ID: 17113426
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.
Tsoukas C; Eyster ME; Shingo S; Mukhopadhyay S; Giallella KM; Curtis SP; Reicin AS; Melian A
Blood; 2006 Mar; 107(5):1785-90. PubMed ID: 16291600
[TBL] [Abstract][Full Text] [Related]
12. [Etoricoxib (Arcoxia)].
Leclercq P; Malaise MG
Rev Med Liege; 2004 May; 59(5):345-9. PubMed ID: 15270001
[TBL] [Abstract][Full Text] [Related]
13. Fixed drug eruption and generalised erythema following etoricoxib.
Augustine M; Sharma P; Stephen J; Jayaseelan E
Indian J Dermatol Venereol Leprol; 2006; 72(4):307-9. PubMed ID: 16880582
[No Abstract] [Full Text] [Related]
14. Cardiovascular and hematologic effects produced by chronic treatment with etoricoxib in normotensive rats.
Baracho NC; Guizelli GP; Carmello BL; Sanches Dde S; Silva FM; Reis JM; Brito Jd
Acta Cir Bras; 2009; 24(3):206-10. PubMed ID: 19504003
[TBL] [Abstract][Full Text] [Related]
15. Etoricoxib-induced erythema-multiforme-like eruption.
Thirion L; Nikkels AF; Piérard GE
Dermatology; 2008; 216(3):227-8. PubMed ID: 18182814
[TBL] [Abstract][Full Text] [Related]
16. Cerebral venous thrombosis in a patient with antiphospholipid syndrome treated with thalidomide.
Pagnoux C; Lutz-Zarrouk V; Michel M; Schaeffer A; Godeau B
Lupus; 2004; 13(6):481-2. PubMed ID: 15303578
[No Abstract] [Full Text] [Related]
17. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study.
Andersohn F; Schade R; Suissa S; Garbe E
Stroke; 2006 Jul; 37(7):1725-30. PubMed ID: 16728684
[TBL] [Abstract][Full Text] [Related]
18. Fixed drug eruption by etoricoxib confirmed by patch test.
Sousa AS; Cardoso JC; Gouveia MP; Gameiro AR; Teixeira VB; Gonçalo M
An Bras Dermatol; 2016; 91(5):652-654. PubMed ID: 27828643
[TBL] [Abstract][Full Text] [Related]
19. Few options available for arthritis pain relief. FDA declines to approve Merck's Arcoxia.
Young D
Am J Health Syst Pharm; 2007 May; 64(10):1020-2. PubMed ID: 17494894
[No Abstract] [Full Text] [Related]
20. Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing.
Andrade P; Gonçalo M
Contact Dermatitis; 2011 Feb; 64(2):118-20. PubMed ID: 21210830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
